IRIS
REFINI, ROSA METELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.601
NA - Nord America 4.538
AS - Asia 550
OC - Oceania 6
AF - Africa 5
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.707
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.519
IT - Italia 1.253
GB - Regno Unito 1.194
IE - Irlanda 821
SE - Svezia 438
CN - Cina 401
UA - Ucraina 282
FR - Francia 203
DE - Germania 192
FI - Finlandia 106
ES - Italia 53
TR - Turchia 51
VN - Vietnam 32
IN - India 24
BE - Belgio 17
CA - Canada 17
IR - Iran 12
RU - Federazione Russa 10
PK - Pakistan 9
AU - Australia 6
AT - Austria 5
PT - Portogallo 5
HK - Hong Kong 4
BR - Brasile 3
CH - Svizzera 3
EU - Europa 3
MA - Marocco 3
BG - Bulgaria 2
GR - Grecia 2
IS - Islanda 2
JP - Giappone 2
KZ - Kazakistan 2
MX - Messico 2
NL - Olanda 2
PH - Filippine 2
PL - Polonia 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
BH - Bahrain 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ID - Indonesia 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
SA - Arabia Saudita 1
SG - Singapore 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 9.707
Salva come PNG Salva come JPEG
Città #
Southend 1.135
Dublin 813
Fairfield 719
Chandler 485
Ashburn 357
Woodbridge 321
Seattle 296
Houston 262
Wilmington 253
Siena 233
Jacksonville 227
Cambridge 226
Ann Arbor 160
Princeton 137
Beijing 122
Dearborn 96
New York 72
Helsinki 68
Nanjing 60
San Mateo 55
Gavirate 48
Málaga 47
Florence 46
Izmir 44
San Diego 40
Boardman 37
Nanchang 33
Dong Ket 32
Shanghai 30
Fremont 29
Catania 28
Rome 28
Milan 27
Brussels 17
Hebei 17
Norwalk 15
Changsha 14
Guangzhou 14
Hefei 13
Shenyang 13
London 12
Menlo Park 12
Kunming 11
Prato 11
Hangzhou 10
Jiaxing 10
Trieste 10
Washington 10
Lahore 9
Lancaster 9
Montecatini Terme 9
Ningbo 9
Redwood City 9
San Francisco 9
Arezzo 8
Napoli 8
Tianjin 8
Zanjan 8
Zhengzhou 8
Düsseldorf 7
Livorno 7
Sesto Fiorentino 7
Duncan 6
Figline Valdarno 6
Grosseto 6
Venezia 6
Chicago 5
Genova 5
Kilburn 5
Ponte Buggianese 5
Saint Louis 5
Tarazona 5
Toronto 5
Bari 4
Bergamo 4
Bologna 4
Empoli 4
Falkenstein 4
Grünheide 4
Jinan 4
Lamézia 4
Los Angeles 4
Montespertoli 4
Pisa 4
Sovicille 4
Vienna 4
Andover 3
Anguillara Sabazia 3
Athis-mons 3
Atlanta 3
Bonndorf 3
Cascina 3
Caserta 3
Cattolica 3
Como 3
Detroit 3
Fisciano 3
Frankfurt am Main 3
Genoa 3
Kocaeli 3
Totale 7.023
Salva come PNG Salva come JPEG
Nome #
La chitotriosidasi: un sensibile biomarker di sarcoidosi 949
Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis 187
Exhaled nitric oxide in interstitial lung diseases 182
Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers 181
Posttransplant solid organ malignancies in lung transplant recipients: A single-center experience and review of the literature 177
Idiopathic pulmonary fibrosis a rare disease with severe bone fragility 174
A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls 173
Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns 170
Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis 168
Diagnosis of idiopathic pulmonary fibrosis by virtual means using “IPFdatabase”- a new software 166
Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress 160
Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience 160
Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease 158
Role of BNP and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: An algorithm application model 157
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial 157
Different effects of inhaled aspirinlike drugs on allergen-induced early and late asthmatic responses 156
The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases 156
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 153
Serum analysis of coagulation factors in IPF and NSIP. 148
Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma 148
Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions 145
Pirfenidone therapy for familial pulmonary fibrosis: a real-life study. 144
null 143
NK and NKT-like cells in granulomatous and fibrotic lung diseases 142
Could NSAIDs have a role as antiasthmatic agents? 138
Steroid-sparing effect of inhaled lysine acetylsalicylate and furosemide in high-dose beclomethasone-dependent asthma 134
Prognostic bioindicators in severe COVID-19 patients 130
Calgranulin B (S100A9/MRP14): a Key molecule in idiopathic pulmonary fibrosis? 122
Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin 121
null 121
Proteomic investigation of pulmonary sarcoidosis 120
P172 Pulmonary Hypertension In Ipf: Utility Of Hrct 119
Bronchoalveolar lavage and serum KL-6 concentrations in chronic hypersensitivity pneumonitis: correlations with radiological and immunological features 119
Time-limited protective effect of inhaled frusemide against aspirin-induced bronchoconstriction in aspirin-sensitive asthmatics 117
Systematic review and metanalysis of oncomarkers in ipf patients and serial changes of oncomarkers in a prospective italian real-life case series 115
Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium 114
New concepts in the pathogenesis of sarcoidosis 114
Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis 110
Postoperative acute kidney injury in lung transplant recipients 110
Protective activity of inhaled nonsteroidal antiinflammatory drugs on bronchial responsiveness to ultrasonically nebulized water 108
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 108
IPF mortality in waiting list for lung transplantation 107
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 107
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 107
null 106
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 105
Exhaled carbon monoxide in sarcoidosis 104
The Role of Urinary Calcium and Chitotriosidase in a Cohort of Chronic Sarcoidosis Patients 104
Utility of spiral CAT scan in the follow-up of patients with pulmonary Largerhans cell histiocytosis 103
Omalizumab treatment in Samter's triad: case series and review of the literature 102
Valutazione dell'ossido nitrico nell'esalato delle polmoniti interstiziali idiopatiche 101
Helicobacter pylori Infection Does Not Impact on Lung Transplant Outcome 100
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female 100
Adaptive immune system in pulmonary sarcoidosis - comparison of peripheral and alveolar biomarkers 99
Adiponectin and leptin levels in idiopathic pulmonary fibrosis: A new method for BAL and serum assessment 99
Inhaled loop diuretics as potential new anti-asthmatic drugs 98
Prognostic role of KL-6 in lymphangioleiomyomatosis patients 93
Mortalità in lista per trapianto di polmone in pazienti affetti da fibrosi polmonare idiopatica 91
Potentiation of the antireactive, antiasthmatic effect of inhaled furosemide by inhaled lysine acetylsalicylate 91
Chitotriosidase: a sensitive biomarker of sarcoidosis 90
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting 89
Familial pulmonary fibrosis: Clinical-functional and radiological features 82
Exhaled carbon monoxide in sarcoidosis 79
Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study 76
Immunologic responses to antifibrotic treatment in IPF patients 76
Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy 74
Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis 70
Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic Review 68
Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study 67
Personalized Approach of Severe Eosinophilic Asthma Patients Treated with Mepolizumab and Benralizumab 64
null 63
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis 60
A functional proteomics approach to the comprehension of sarcoidosis 58
Hypercalciuria in Sarcoidosis: A Specific Biomarker With Clinical Utility 55
Acute exacerbation of idiopathic pulmonary fibrosis after inhalation of a water repellent 50
Exhaled nitric oxide and carbon monoxide in lung transplanted patients 47
Chitotriosidase analysis in bronchoalveolar lavage of patients with sarcoidosis. 44
The role of the combination of echo-HRCT score as a tool to evaluate the presence of pulmonary hypertension in idiopathic pulmonary fibrosis 43
Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction 34
Immune checkpoint analysis of T-cell responses to pp65 and IE-1 antigens in end-stage lung diseases 19
Exploring the Interaction between Fractional Exhaled Nitric Oxide and Biologic Treatment in Severe Asthma: A Systematic Review 19
Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis 18
Calgranulin B/S100A9 and KL-6 in bronchoalveolar lavage of patients with IPF and NSIP 15
The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study 15
Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP 14
Nintedanib in Idiopathic Pulmonary Fibrosis: a single-centre real-life experience 10
Real-life comparison between pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis 10
Human chitotriosidase analysis: a reliable biomarker of sarcoidosis severity 7
Serum concentrations of KL-6 in patients with IPF and lung cancer and serial measurements of KL-6 in IPF patients treated with antifibrotic therapy 6
The value of urinary calcium as biomarker in chronic sarcoidosis 6
Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases 2
Erratum: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis (Respiratory Research (2020) 21 (6) DOI: 10.1186/s12931-019-1263-z) 2
Totale 9.923
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.689
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019474 0 0 0 0 0 0 0 0 0 0 271 203
2019/20201.898 171 76 84 248 132 196 214 229 185 172 70 121
2020/20211.817 64 166 63 151 187 224 135 254 152 148 147 126
2021/20221.302 88 157 111 110 68 47 59 51 45 146 169 251
2022/20231.589 106 170 208 195 148 285 57 123 160 63 44 30
2023/20241.210 45 22 119 57 68 346 456 40 9 43 5 0
Totale 9.923